Dr. Nathalia Ferreira
Head of Preclinical Validation
-
Plans and executes cell studies.
-
Documents study results.
-
Designs animal studies and coordinates with Contract Research Organisations (CROs).
-
Communicates with regulatory affairs consultants.
-
Presents scientific results to the public.
Biosketch
Dr. Nathalia Ferreira, head of preclinical validation, has completed her PhD in Molecular Medicine at the Max Planck Institute for Multidisciplinary Sciences (MPI-NAT) under supervision of Prof. Frauke Alves, focusing on the preclinical evaluation of nanovaccines in patient-derived organoids, especially pancreatic cancer/ immune cell co-cultures. She has been a vital part of the NanoDrug Delivery team since early 2024, bringing her extensive experience in preclinical research and pancreatic cancer studies to support the company. During her doctorate, Nathalia already worked in collaboration with Miltenyi Biotec on cancer therapy, where she gained valuable industry experience.
Contact
Passionate about translating preclinical findings into therapeutic progress.
Let’s get in touch to collaborate.